- $36.46m
- $38.12m
- 17
- 48
- 51
- 32
Annual income statement for Blue Biofuels, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1.99 | 2.11 | 3.93 | 3.19 | 1.64 |
| Operating Profit | -1.99 | -2.11 | -3.93 | -3.19 | -1.64 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.18 | -2.14 | -3.96 | -3.06 | -1.42 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.18 | -2.14 | -3.96 | -3.06 | -1.42 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.18 | -2.14 | -3.96 | -3.06 | -1.42 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.18 | -2.14 | -3.96 | -3.06 | -1.42 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.009 | -0.008 | -0.014 | -0.01 | -0.013 |